S3 Ventures

Founded in 2005, S3 Ventures is the largest and longest-serving venture capital firm native to Texas. Headquartered in Austin, the firm has spent two decades backing transformative technology companies from seed through Series B, amassing a portfolio that has collectively raised over $3.5 billion. Understanding NRR and why top quartile exceeds 120% is valuable for any founder.

In December 2025, S3 Ventures closed its eighth fund at $250 million, bringing total assets under management to over $1 billion. The firm's unique single-LP structure—a philanthropic family foundation—means S3 operates with patient capital unencumbered by traditional VC timing pressures. This allows them to truly partner with founders through multiple market cycles.

S3 Ventures focuses its investments on two sectors: Business Software and Healthcare Technology. The firm is known for leading rounds, writing initial checks from $500,000 to $15 million, with capacity to invest more than $25 million over a company's lifetime. Roughly half their capital stays in Texas, though they explicitly state they do not limit geography: talented founders are everywhere.

With 40+ active portfolio companies and 35+ exits collectively valued at over $3 billion, S3 Ventures has built one of the most successful track records in the Southwest. Their team includes Managing Director Brian R. Smith, General Partners Charlie Plauche, Eric Engineer, and Aaron Perman, along with an operations team focused on platform and network support.

This guide covers S3's investment thesis, their active portfolio, what they look for in founders, and practical advice for getting on their radar.

S3 Ventures invests in transformative Business Software and Healthcare Technology companies at the seed through Series B stages. Their approach is captured in their tagline: "Patient Capital. True Resources. Big Impacts." Understanding SaaS unit economics and LTV:CAC is valuable for any founder.

The firm's single-LP structure—a highly-philanthropic family foundation—is central to their identity. With no outside LP pressure to return capital on a traditional timeline, S3 can make long-term bets on founders and stay invested through volatility. They describe themselves as undistracted by fundraising and unencumbered by timing constraints.

S3 typically leads or co-leads rounds, which means they expect meaningful ownership and involvement. Their initial check range of $500,000 to $15 million positions them to lead seed rounds, Series A, and Series B investments. With up to $25 million available over a company's lifecycle, they can support portfolio companies through multiple financing rounds.

While roughly half of S3's capital stays in Texas—particularly Austin, Dallas, and Houston—they explicitly do not limit their geographic focus. "Talented founders are everywhere" is a core belief. Portfolio companies span from North Carolina to Colorado to Oregon.

S3 provides more than capital. Their platform team offers operational support, network access, and strategic guidance. The firm emphasizes being true partners who "show up, dig in, and help solve real problems" rather than passive investors.

The firm is sector-agnostic within their two verticals. Business Software investments span DevOps analytics (Allstacks), cloud disaster recovery (Arpio), construction staffing (Buildforce), tax technology (Ceretax), AI security operations (Crogl), and database DevOps (Liquibase). Healthcare Technology investments include medical devices like Endovascular Engineering's thrombectomy systems, diagnostics, and health IT platforms like Braincheck's cognitive assessment tools.

December 2025 marked a significant milestone: S3 Ventures closed its $250 million Fund VIII, the largest fund in the firm's 20-year history. This came on the heels of a decade of strong performance, with 35+ portfolio exits valued at over $3 billion. Understanding healthcare financial benchmarks is valuable for any founder.

Fund VIII continues the firm's thesis of investing in Business Software and Healthcare Technology, with initial checks ranging from $500,000 to $15 million. The firm retains capacity to invest more than $25 million in any single company over its lifetime, ensuring they can support winners through growth stages.

Recent additions to the portfolio include companies across AI infrastructure, healthcare devices, and vertical SaaS. The firm has been particularly active in AI-related investments, with portfolio companies like Sunthetics (AI-driven chemistry), Kamiwaza (AI orchestration), and Mavvrik (AI cost governance) reflecting the current wave of enterprise AI adoption.

S3's patient capital model has proven attractive to founders who want a partner that won't push for premature exits. With the fund's long-horizon structure, S3 can afford to let companies mature and find product-market fit rather than forcing growth to meet fund timelines.

The firm continues to lead rounds in the Texas ecosystem while maintaining a national aperture. Austin remains their home base, but portfolio companies are scattered across the country—from Cambridge to Denver to Portland.

S3 Ventures has invested in over 75 companies since inception, with 40+ currently active. Here's a snapshot of notable portfolio companies across their two sectors:

Business Software portfolio includes Allstacks (predictive DevOps analytics), Arpio (cloud disaster recovery), AtmosphereTV (streaming TV for businesses), Avtal (automated collections), Buildforce (construction staffing), Ceretax (indirect tax calculation), Controlrooms (industrial troubleshooting), Crogl (AI security operations), Hydrolix (streaming data lake), Interplay Learning (virtual training for skilled trades), Kamiwaza (AI orchestration), Leandna (factory management software), Liquibase (database DevOps), Mavvrik (AI cost governance), Montycloud (CloudOps automation), Nestimate (retirement income solutions), Opine (technical sales intelligence), Prokeep (messaging for distributors), Repvue (sales team sentiment platform), Schematic (SaaS and AI monetization platform), Stellar (rental maintenance marketplace), Suite Studios (cloud-native file streaming), Sunthetics (AI-driven chemistry), Upequity (tech-powered mortgage solutions), Videate (AI-powered video production), Zsuite Tech (digital escrow solutions), and Nexusgg (game influencer programs).

Healthcare Technology portfolio includes Alleviant Medical (interatrial shunt therapy for heart failure), Braincheck (cognitive assessment and care platforms), Databahn (healthcare data pipeline management), Endovascular Engineering (thrombectomy systems), Flex Vascular (endovascular devices), Folia Health (home reported outcomes), Ictero (gallbladder cryoablation), Qbdvision (biopharma data platform), Vahaticor (CMD therapy), and Versa (tricuspid valve repair).

Hardware investments include Mythic (analog AI-compute) and Vuv Analytics (universal detector).

Notable exits include multiple companies across enterprise software and healthcare that have collectively returned significant capital to LPs. The firm's exit strategy typically involves strategic acquisitions or public offerings, with exits spread across major technology and healthcare M&A activity.

S3 Ventures evaluates opportunities based on several factors, with the founding team at the top of the list. The firm looks for entrepreneurs with deep domain expertise, a clear vision for transforming their market, and the operational ability to build a company over many years—not just to a quick exit.

Market opportunity matters significantly. S3 targets large, growing markets with the potential for meaningful revenue. Within Business Software, they focus on vertical SaaS, DevOps, AI infrastructure, and enterprise productivity tools. In Healthcare Technology, they look at medical devices, diagnostics, health IT, and care delivery platforms.

Product differentiation is critical. S3 seeks companies with proprietary technology, unique data assets, or novel approaches that create durable competitive advantages. The firm has seen thousands of pitches—their differentiation radar is well-calibrated.

Traction indicators vary by stage. Seed-stage companies should show early evidence of product-market fit: customer validation, revenue traction, or strong engagement metrics. Series A companies should demonstrate clear growth trajectories and SaaS unit economics that support scaling.

S3 prefers to lead rounds, which means they want meaningful ownership. Founders should be prepared to discuss valuation expectations, cap tables, and their path to ownership. The firm also looks for companies with capital-efficient models—when capital is cheap, the bar is lower, but S3's patient approach means they still scrutinize burn and runway.

Cultural fit matters. S3 describes their approach as operationally oriented—they show up and help solve real problems. Founders who want a purely passive investor may be a better fit elsewhere. S3 expects engaged partnerships where the firm can add value beyond capital.

The best way to get on S3 Ventures' radar is through a warm introduction. The firm explicitly values relationships with portfolio founders, other trusted investors, and members of the Texas entrepreneurial community who can vouch for a founder's capabilities and character.

If you don't have an immediate connection, focus on building relationships in the Austin ecosystem. S3 is embedded in the local tech community and maintains a strong deal flow from Texas accelerators, VCs, and founders who have exited or been funded previously. Attending local events and building genuine connections before pitching will significantly improve your odds.

S3 does accept cold submissions, but the firm is selective. A cold pitch should be concise, clearly articulate your differentiation and why you fit S3's thesis, and demonstrate that you understand their focus areas. Don't send generic decks—tailor your message to show you've done your homework on S3 specifically.

When you get a meeting, expect a substantive conversation. S3's partners are operator-oriented and will dig into your business model, market assumptions, competitive positioning, and team background. They'll challenge your projections and probe for blind spots. Come prepared with honest answers, not just polished talking points.

Follow-up discipline matters. S3 typically runs a 2-4 week due diligence process after an initial meeting, though timing varies by deal complexity and firm bandwidth. Maintain communication without being pushy—send material updates on milestones and avoid flooding them with incremental information.

Even if your current round doesn't result in an investment, building a relationship with S3 can pay off later. They may be interested in future rounds, can introduce you to other investors, or may be the right partner when your company matures. Think long-term with this firm.

While S3 Ventures invests in early-stage companies, they expect founders to have a solid command of their financials. This means understanding burn rate, runway, SaaS unit economics, and a realistic path to profitability—or to the next funding round.

S3's team includes experienced operators who will scrutinize your financial模型. They're looking for founders who understand their numbers intimately, not just at a high level. Be prepared to walk through your model in detail, explain your key assumptions, and demonstrate you've stress-tested your projections.

Working with a fractional CFO can significantly strengthen your pitch. Professional financial guidance helps you build investor-ready materials, realistic projections, and the confidence to defend your numbers in due diligence. S3 respects founders who've done the work to understand their SaaS unit economics.

Key metrics vary by sector but always include the metrics that matter for your specific business. For SaaS companies, this means ARR benchmarks growth, net revenue retention, and customer acquisition costs. For healthcare device companies, regulatory milestones and clinical data may be more relevant. Know your numbers cold.

Financial projections should be grounded in evidence, not optimistic hockey-stick scenarios. S3 will challenge your assumptions—be ready to explain the basis for your forecasts and show you've considered downside cases.

Our team has helped numerous companies prepare for fundraising and would be happy to discuss how we can support your process.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you're raising a seed round or Series B, you'll find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.